FDA Green Lights Bizengri Drug To Treat Rare, Aggressive Bile Duct Cancer MedNews
MONDAY, May 11, 2026 The U.S. Food and Drug Administration (FDA) has approved Bizengri to treat an ultra-rare, aggressive cancer that forms in the bile ducts. B
When a Child is Going Through Cancer Treatment, Nutrition Can Play a Vital Role – World Child Cancer / cancer, OncoDaily, Oncology, UK Aid Match, World child Post Views: 2
The prenatal nutrition industry is moving toward targeted, science-backed solutions that benefit maternal and infant wellness. In this space, Aker BioMarine says docosahexaenoic acid (DHA) omega-3 is gaining renewed attention in the